Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-05 Sale | 2024-02-07 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,600 | $17.45 | $80,249 | 111,539 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,600 | $19.16 | $88,116 | 116,139 (Direct) | View |
| 2023-12-05 Sale | 2023-12-07 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,600 | $16.3 | $74,996 | 120,739 (Direct) | View |
| 2023-11-22 Sale | 2023-11-27 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 13,800 | $15 | $207,000 | 125,339 (Direct) | View |
| 2023-07-05 Sale | 2023-07-07 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $17.3 | $38,915 | 139,139 (Direct) | View |
| 2023-06-05 Sale | 2023-06-07 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $16.26 | $36,576 | 141,389 (Direct) | View |
| 2023-05-05 Sale | 2023-05-09 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $20.87 | $46,957 | 143,639 (Direct) | View |
| 2023-04-05 Sale | 2023-04-07 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $18.2 | $40,942 | 145,889 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $23.75 | $53,440 | 148,139 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $24.27 | $54,612 | 212,389 (Direct) | View |
| 2023-01-05 Sale | 2023-01-09 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $26.4 | $59,405 | 152,639 (Direct) | View |
| 2022-12-05 Sale | 2022-12-07 6:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $17.38 | $39,114 | 154,889 (Direct) | View |
| 2022-11-07 Sale | 2022-11-09 5:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $19.2 | $43,194 | 157,139 (Direct) | View |
| 2022-10-05 Sale | 2022-10-07 5:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $15.75 | $35,447 | 159,389 (Direct) | View |
| 2022-09-06 Sale | 2022-09-07 5:30 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer | 2,250 | $19 | $42,750 | 161,639 (Direct) | View |
| 2022-08-18 Sale | 2022-08-19 5:00 pm | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer | 2,250 | $21.18 | $47,657 | 163,889 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-05 Exercise | 2024-02-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 3,200 | $2.14 | 111,539 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,400 | $1.74 | 111,539 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-07 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,600 | $0 | 111,539 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 6:00 pm | N/A 2034-01-21 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 66,586 | $0 | 66,586 (Direct) | View |
| 2024-01-05 Exercise | 2024-01-08 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 3,200 | $2.14 | 116,139 (Direct) | View |
| 2024-01-05 Exercise | 2024-01-08 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,400 | $1.74 | 116,139 (Direct) | View |
| 2024-01-05 Exercise | 2024-01-08 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,600 | $0 | 116,139 (Direct) | View |
| 2023-12-05 Exercise | 2023-12-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 3,200 | $2.14 | 120,739 (Direct) | View |
| 2023-12-05 Exercise | 2023-12-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,400 | $1.74 | 120,739 (Direct) | View |
| 2023-12-05 Exercise | 2023-12-07 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,600 | $0 | 120,739 (Direct) | View |
| 2023-11-22 Exercise | 2023-11-27 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 9,600 | $2.14 | 125,339 (Direct) | View |
| 2023-11-22 Exercise | 2023-11-27 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 4,200 | $1.74 | 125,339 (Direct) | View |
| 2023-11-22 Exercise | 2023-11-27 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 13,800 | $0 | 125,339 (Direct) | View |
| 2023-07-05 Exercise | 2023-07-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,600 | $2.14 | 139,139 (Direct) | View |
| 2023-07-05 Exercise | 2023-07-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 650 | $1.74 | 139,139 (Direct) | View |
| 2023-07-05 Exercise | 2023-07-07 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $0 | 139,139 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,600 | $2.14 | 141,389 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 650 | $1.74 | 141,389 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-07 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $0 | 141,389 (Direct) | View |
| 2023-05-05 Exercise | 2023-05-09 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,600 | $2.14 | 143,639 (Direct) | View |
| 2023-05-05 Exercise | 2023-05-09 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 650 | $1.74 | 143,639 (Direct) | View |
| 2023-05-05 Exercise | 2023-05-09 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $0 | 143,639 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,600 | $2.14 | 145,889 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 650 | $1.74 | 145,889 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $0 | 145,889 (Direct) | View |
| 2023-03-06 Exercise | 2023-03-08 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,600 | $2.14 | 148,139 (Direct) | View |
| 2023-03-06 Exercise | 2023-03-08 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 650 | $1.74 | 148,139 (Direct) | View |
| 2023-03-06 Exercise | 2023-03-08 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $0 | 148,139 (Direct) | View |
| 2023-02-06 Exercise | 2023-02-08 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,600 | $2.14 | 212,389 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-08 6:00 pm | N/A 2033-02-06 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 62,000 | $0 | 212,389 (Direct) | View |
| 2023-02-06 Exercise | 2023-02-08 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 650 | $1.74 | 212,389 (Direct) | View |
| 2023-02-06 Exercise | 2023-02-08 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $0 | 212,389 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-09 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,600 | $2.14 | 152,639 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-09 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 650 | $1.74 | 152,639 (Direct) | View |
| 2023-01-05 Exercise | 2023-01-09 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $0 | 152,639 (Direct) | View |
| 2022-12-05 Exercise | 2022-12-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,600 | $2.14 | 154,889 (Direct) | View |
| 2022-12-05 Exercise | 2022-12-07 6:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 650 | $1.74 | 154,889 (Direct) | View |
| 2022-12-05 Exercise | 2022-12-07 6:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $0 | 154,889 (Direct) | View |
| 2022-11-07 Exercise | 2022-11-09 5:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,600 | $2.14 | 157,139 (Direct) | View |
| 2022-11-07 Exercise | 2022-11-09 5:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 650 | $1.74 | 157,139 (Direct) | View |
| 2022-11-07 Exercise | 2022-11-09 5:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $0 | 157,139 (Direct) | View |
| 2022-10-05 Exercise | 2022-10-07 5:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 1,600 | $2.14 | 159,389 (Direct) | View |
| 2022-10-05 Exercise | 2022-10-07 5:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 650 | $1.74 | 159,389 (Direct) | View |
| 2022-10-05 Exercise | 2022-10-07 5:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH CHIEF SCIENTIFIC OFFICER | 2,250 | $0 | 159,389 (Direct) | View |
| 2022-09-06 Exercise | 2022-09-07 5:30 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer | 1,600 | $2.14 | 161,639 (Direct) | View |
| 2022-09-06 Exercise | 2022-09-07 5:30 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer | 650 | $1.74 | 161,639 (Direct) | View |
| 2022-09-06 Exercise | 2022-09-07 5:30 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer | 2,250 | $0 | 161,639 (Direct) | View |
| 2022-08-18 Exercise | 2022-08-19 5:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer | 1,600 | $2.14 | 163,889 (Direct) | View |
| 2022-08-18 Exercise | 2022-08-19 5:00 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer | 650 | $1.74 | 163,889 (Direct) | View |
| 2022-08-18 Exercise | 2022-08-19 5:00 pm | N/A 2030-09-03 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Scientific Officer | 2,250 | $0 | 163,889 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-16 6:00 pm | N/A 2031-12-13 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Development Officer | 65,433 | $0 | 65,433 (Direct) | View |
| 2021-04-02 Option Award | 2021-07-01 6:35 pm | N/A 2031-04-01 | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Development Officer | 152,234 | $0 | 152,234 (Direct) | View |
Ownership | 2021-06-29 7:42 pm | N/A N/A | Aerovate Therapeutics Inc. | AVTE | NIVEN RALPH Chief Development Officer | 0 | $0 | 166,139 (Direct) | View |